Financhill
Buy
53

USPH Quote, Financials, Valuation and Earnings

Last price:
$75.66
Seasonality move :
2.42%
Day range:
$73.40 - $75.66
52-week range:
$62.77 - $101.20
Dividend yield:
2.4%
P/E ratio:
34.07x
P/S ratio:
1.60x
P/B ratio:
2.27x
Volume:
213.1K
Avg. volume:
154.8K
1-year change:
-17.9%
Market cap:
$1.1B
Revenue:
$671.3M
EPS (TTM):
$2.18

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
USPH
US Physical Therapy
$176.8M $0.45 13.42% 48.58% $106.00
DVA
DaVita
$3.2B $2.02 5.28% 10.44% $159.15
EHC
Encompass Health
$1.4B $1.19 9.58% 7.68% $131.58
MD
Pediatrix Medical Group
$451.4M $0.24 -7.37% 382.8% $17.14
NAKA
Kindly MD
-- -- -- -- --
TOI
The Oncology Institute
$119.5M -$0.10 14.19% -52.63% $7.00
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
USPH
US Physical Therapy
$74.28 $106.00 $1.1B 34.07x $0.45 2.4% 1.60x
DVA
DaVita
$136.34 $159.15 $10.3B 13.51x $0.00 0% 0.89x
EHC
Encompass Health
$120.22 $131.58 $12.1B 24.84x $0.17 0.55% 2.23x
MD
Pediatrix Medical Group
$13.37 $17.14 $1.1B -- $0.00 0% 0.57x
NAKA
Kindly MD
$16.30 -- $121.6M -- $0.00 0% 37.88x
TOI
The Oncology Institute
$2.39 $7.00 $213.3M -- $0.00 0% 0.45x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
USPH
US Physical Therapy
25.08% 1.841 12.74% 1.05x
DVA
DaVita
102.82% 1.528 70.83% 1.12x
EHC
Encompass Health
53.38% 0.316 22.48% 0.84x
MD
Pediatrix Medical Group
43.7% 2.035 49.27% 1.74x
NAKA
Kindly MD
3.83% 42.592 0.63% 2.05x
TOI
The Oncology Institute
93.58% -3.677 72.89% 1.50x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
USPH
US Physical Therapy
$31.1M $14.8M 3.81% 4.62% 10.67% -$7.3M
DVA
DaVita
$983.9M $433.3M 7.42% 38.96% 13.07% $36.8M
EHC
Encompass Health
$630.9M $267M 9.36% 18.4% 18.58% $125.5M
MD
Pediatrix Medical Group
$102.6M $38.7M -5.85% -10.7% 8.13% -$120.8M
NAKA
Kindly MD
$571.7K -$1M -173.97% -188.85% -177.98% -$1M
TOI
The Oncology Institute
$17.2M -$9.9M -60.54% -340.01% -13.42% -$5.3M

US Physical Therapy vs. Competitors

  • Which has Higher Returns USPH or DVA?

    DaVita has a net margin of 6.97% compared to US Physical Therapy's net margin of 5.05%. US Physical Therapy's return on equity of 4.62% beat DaVita's return on equity of 38.96%.

    Company Gross Margin Earnings Per Share Invested Capital
    USPH
    US Physical Therapy
    16.9% $0.80 $925.5M
    DVA
    DaVita
    30.52% $2.00 $11.4B
  • What do Analysts Say About USPH or DVA?

    US Physical Therapy has a consensus price target of $106.00, signalling upside risk potential of 42.7%. On the other hand DaVita has an analysts' consensus of $159.15 which suggests that it could grow by 16.73%. Given that US Physical Therapy has higher upside potential than DaVita, analysts believe US Physical Therapy is more attractive than DaVita.

    Company Buy Ratings Hold Ratings Sell Ratings
    USPH
    US Physical Therapy
    2 1 0
    DVA
    DaVita
    1 8 0
  • Is USPH or DVA More Risky?

    US Physical Therapy has a beta of 1.451, which suggesting that the stock is 45.087% more volatile than S&P 500. In comparison DaVita has a beta of 1.107, suggesting its more volatile than the S&P 500 by 10.674%.

  • Which is a Better Dividend Stock USPH or DVA?

    US Physical Therapy has a quarterly dividend of $0.45 per share corresponding to a yield of 2.4%. DaVita offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. US Physical Therapy pays 100.3% of its earnings as a dividend. DaVita pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios USPH or DVA?

    US Physical Therapy quarterly revenues are $183.8M, which are smaller than DaVita quarterly revenues of $3.2B. US Physical Therapy's net income of $12.8M is lower than DaVita's net income of $162.9M. Notably, US Physical Therapy's price-to-earnings ratio is 34.07x while DaVita's PE ratio is 13.51x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for US Physical Therapy is 1.60x versus 0.89x for DaVita. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    USPH
    US Physical Therapy
    1.60x 34.07x $183.8M $12.8M
    DVA
    DaVita
    0.89x 13.51x $3.2B $162.9M
  • Which has Higher Returns USPH or EHC?

    Encompass Health has a net margin of 6.97% compared to US Physical Therapy's net margin of 10.41%. US Physical Therapy's return on equity of 4.62% beat Encompass Health's return on equity of 18.4%.

    Company Gross Margin Earnings Per Share Invested Capital
    USPH
    US Physical Therapy
    16.9% $0.80 $925.5M
    EHC
    Encompass Health
    43.35% $1.48 $5.4B
  • What do Analysts Say About USPH or EHC?

    US Physical Therapy has a consensus price target of $106.00, signalling upside risk potential of 42.7%. On the other hand Encompass Health has an analysts' consensus of $131.58 which suggests that it could grow by 9.45%. Given that US Physical Therapy has higher upside potential than Encompass Health, analysts believe US Physical Therapy is more attractive than Encompass Health.

    Company Buy Ratings Hold Ratings Sell Ratings
    USPH
    US Physical Therapy
    2 1 0
    EHC
    Encompass Health
    11 0 0
  • Is USPH or EHC More Risky?

    US Physical Therapy has a beta of 1.451, which suggesting that the stock is 45.087% more volatile than S&P 500. In comparison Encompass Health has a beta of 0.903, suggesting its less volatile than the S&P 500 by 9.671%.

  • Which is a Better Dividend Stock USPH or EHC?

    US Physical Therapy has a quarterly dividend of $0.45 per share corresponding to a yield of 2.4%. Encompass Health offers a yield of 0.55% to investors and pays a quarterly dividend of $0.17 per share. US Physical Therapy pays 100.3% of its earnings as a dividend. Encompass Health pays out 13.78% of its earnings as a dividend. Encompass Health's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but US Physical Therapy's is not.

  • Which has Better Financial Ratios USPH or EHC?

    US Physical Therapy quarterly revenues are $183.8M, which are smaller than Encompass Health quarterly revenues of $1.5B. US Physical Therapy's net income of $12.8M is lower than Encompass Health's net income of $151.5M. Notably, US Physical Therapy's price-to-earnings ratio is 34.07x while Encompass Health's PE ratio is 24.84x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for US Physical Therapy is 1.60x versus 2.23x for Encompass Health. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    USPH
    US Physical Therapy
    1.60x 34.07x $183.8M $12.8M
    EHC
    Encompass Health
    2.23x 24.84x $1.5B $151.5M
  • Which has Higher Returns USPH or MD?

    Pediatrix Medical Group has a net margin of 6.97% compared to US Physical Therapy's net margin of 4.52%. US Physical Therapy's return on equity of 4.62% beat Pediatrix Medical Group's return on equity of -10.7%.

    Company Gross Margin Earnings Per Share Invested Capital
    USPH
    US Physical Therapy
    16.9% $0.80 $925.5M
    MD
    Pediatrix Medical Group
    22.39% $0.24 $1.4B
  • What do Analysts Say About USPH or MD?

    US Physical Therapy has a consensus price target of $106.00, signalling upside risk potential of 42.7%. On the other hand Pediatrix Medical Group has an analysts' consensus of $17.14 which suggests that it could grow by 28.22%. Given that US Physical Therapy has higher upside potential than Pediatrix Medical Group, analysts believe US Physical Therapy is more attractive than Pediatrix Medical Group.

    Company Buy Ratings Hold Ratings Sell Ratings
    USPH
    US Physical Therapy
    2 1 0
    MD
    Pediatrix Medical Group
    3 5 0
  • Is USPH or MD More Risky?

    US Physical Therapy has a beta of 1.451, which suggesting that the stock is 45.087% more volatile than S&P 500. In comparison Pediatrix Medical Group has a beta of 1.269, suggesting its more volatile than the S&P 500 by 26.911%.

  • Which is a Better Dividend Stock USPH or MD?

    US Physical Therapy has a quarterly dividend of $0.45 per share corresponding to a yield of 2.4%. Pediatrix Medical Group offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. US Physical Therapy pays 100.3% of its earnings as a dividend. Pediatrix Medical Group pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios USPH or MD?

    US Physical Therapy quarterly revenues are $183.8M, which are smaller than Pediatrix Medical Group quarterly revenues of $458.4M. US Physical Therapy's net income of $12.8M is lower than Pediatrix Medical Group's net income of $20.7M. Notably, US Physical Therapy's price-to-earnings ratio is 34.07x while Pediatrix Medical Group's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for US Physical Therapy is 1.60x versus 0.57x for Pediatrix Medical Group. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    USPH
    US Physical Therapy
    1.60x 34.07x $183.8M $12.8M
    MD
    Pediatrix Medical Group
    0.57x -- $458.4M $20.7M
  • Which has Higher Returns USPH or NAKA?

    Kindly MD has a net margin of 6.97% compared to US Physical Therapy's net margin of -179.07%. US Physical Therapy's return on equity of 4.62% beat Kindly MD's return on equity of -188.85%.

    Company Gross Margin Earnings Per Share Invested Capital
    USPH
    US Physical Therapy
    16.9% $0.80 $925.5M
    NAKA
    Kindly MD
    98.64% -$0.17 $1.6M
  • What do Analysts Say About USPH or NAKA?

    US Physical Therapy has a consensus price target of $106.00, signalling upside risk potential of 42.7%. On the other hand Kindly MD has an analysts' consensus of -- which suggests that it could fall by --. Given that US Physical Therapy has higher upside potential than Kindly MD, analysts believe US Physical Therapy is more attractive than Kindly MD.

    Company Buy Ratings Hold Ratings Sell Ratings
    USPH
    US Physical Therapy
    2 1 0
    NAKA
    Kindly MD
    0 0 0
  • Is USPH or NAKA More Risky?

    US Physical Therapy has a beta of 1.451, which suggesting that the stock is 45.087% more volatile than S&P 500. In comparison Kindly MD has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock USPH or NAKA?

    US Physical Therapy has a quarterly dividend of $0.45 per share corresponding to a yield of 2.4%. Kindly MD offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. US Physical Therapy pays 100.3% of its earnings as a dividend. Kindly MD pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios USPH or NAKA?

    US Physical Therapy quarterly revenues are $183.8M, which are larger than Kindly MD quarterly revenues of $579.7K. US Physical Therapy's net income of $12.8M is higher than Kindly MD's net income of -$1M. Notably, US Physical Therapy's price-to-earnings ratio is 34.07x while Kindly MD's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for US Physical Therapy is 1.60x versus 37.88x for Kindly MD. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    USPH
    US Physical Therapy
    1.60x 34.07x $183.8M $12.8M
    NAKA
    Kindly MD
    37.88x -- $579.7K -$1M
  • Which has Higher Returns USPH or TOI?

    The Oncology Institute has a net margin of 6.97% compared to US Physical Therapy's net margin of -18.76%. US Physical Therapy's return on equity of 4.62% beat The Oncology Institute's return on equity of -340.01%.

    Company Gross Margin Earnings Per Share Invested Capital
    USPH
    US Physical Therapy
    16.9% $0.80 $925.5M
    TOI
    The Oncology Institute
    16.52% -$0.21 $79M
  • What do Analysts Say About USPH or TOI?

    US Physical Therapy has a consensus price target of $106.00, signalling upside risk potential of 42.7%. On the other hand The Oncology Institute has an analysts' consensus of $7.00 which suggests that it could grow by 192.89%. Given that The Oncology Institute has higher upside potential than US Physical Therapy, analysts believe The Oncology Institute is more attractive than US Physical Therapy.

    Company Buy Ratings Hold Ratings Sell Ratings
    USPH
    US Physical Therapy
    2 1 0
    TOI
    The Oncology Institute
    1 0 0
  • Is USPH or TOI More Risky?

    US Physical Therapy has a beta of 1.451, which suggesting that the stock is 45.087% more volatile than S&P 500. In comparison The Oncology Institute has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock USPH or TOI?

    US Physical Therapy has a quarterly dividend of $0.45 per share corresponding to a yield of 2.4%. The Oncology Institute offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. US Physical Therapy pays 100.3% of its earnings as a dividend. The Oncology Institute pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios USPH or TOI?

    US Physical Therapy quarterly revenues are $183.8M, which are larger than The Oncology Institute quarterly revenues of $104.4M. US Physical Therapy's net income of $12.8M is higher than The Oncology Institute's net income of -$19.6M. Notably, US Physical Therapy's price-to-earnings ratio is 34.07x while The Oncology Institute's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for US Physical Therapy is 1.60x versus 0.45x for The Oncology Institute. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    USPH
    US Physical Therapy
    1.60x 34.07x $183.8M $12.8M
    TOI
    The Oncology Institute
    0.45x -- $104.4M -$19.6M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Warren Buffett Buy Amazon Stock?
Why Did Warren Buffett Buy Amazon Stock?

When investors think of tech stocks in Warren Buffett’s portfolio,…

Where Will RocketLab Stock Be In 5 Years?
Where Will RocketLab Stock Be In 5 Years?

Rocket Lab (NASDAQ: RKLB) closed recently at around $30 per share,…

Is MO dividend Worth It?
Is MO dividend Worth It?

Altria Group (NYSE: MO) is paying investors $1.02 a share…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.6T
P/E Ratio: 41x

Buy
59
Is NVDA Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 49x

Sell
45
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Buy
88
CDTX alert for Jun 24

Cidara Therapeutics [CDTX] is up 3.56% over the past day.

Sell
46
HIMS alert for Jun 24

Hims & Hers Health [HIMS] is up 3.22% over the past day.

Buy
67
WGS alert for Jun 24

GeneDx Holdings [WGS] is up 12.04% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock